title: The latest prospects of investigational drugs for head and neck cancer.
authors.affiliation: a Department of Radiation Oncology , Inselspital, Bern University Hospital and University of Bern , Bern , Switzerland.
authors.forename: Olgun
authors.initials: O
authors.lastname: Elicin
authors.affiliation: b Department of Radiation Oncology , University of Lausanne, Centre Hospitalier Universitaire Vaudois (CHUV) , Lausanne , Switzerland.
authors.forename: Mahmut
authors.initials: M
authors.lastname: Ozsahin
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy*; D015195:Drug Design; D015507:Drugs, Investigational / Q000008:administration & dosage / Q000627:therapeutic use*; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000628:therapy*; D006801:Humans; D000077195:Squamous Cell Carcinoma of Head and Neck
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational
keywords: Chemotherapy; drug development; head and neck cancer; systemic treatment; targeted therapy